HealthNewsAPI
Two common drugs may reverse fatty liver disease, study finds - ScienceDaily
Overview
Scientists report that combining two existing drugs dramatically reduced liver fat in animal models of metabolic dysfunction-associated steatotic liver disease (MASLD) and improved markers of liver health. The aging-activated belly-fat stem cell discovery points to shared mechanisms driving age-related fat accumulation in liver and abdomen, suggesting combination drug approaches might be complemented by therapies targeting those stem cells. These are preclinical results that will require clinical trials to confirm safety and effectiveness in people.
Entities
ORGScienceDailyLOCworldwide
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 3 · Connections: 2
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.